Mark Miller, MD
Otolaryngology · Medford, ORNPI 1689025827
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Medical Device Business Services, Inc. at 54.4% of the total. Reporting peaked in 2019 at $920 and has fallen 76.7% since, to $215 in 2025.
Across 22 payments — averaging $70.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$848
- Smith+Nephew$166
- Medtronic$126
- Sanofi$121
- Regeneron Healthcare Solutions, Inc.$98
- Acclarent, Inc$38
- plus $162 from 7 others
What the payments were for
- Travel & lodging$80051%
- Food & beverage$59238%
- Education$16611%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 4 | $848 |
| Smith+Nephew | 1 | $166 |
| Medtronic | 2 | $126 |
| Sanofi | 5 | $121 |
| Regeneron Healthcare Solutions, Inc. | 1 | $98 |
| Acclarent, Inc | 2 | $38 |
| Grace Medical, Inc. | 1 | $34 |
| Aerin Medical Inc. | 1 | $33 |
| Amgen | 1 | $24 |
| KARL Storz Endoscopy-america | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Stryker | 1 | $19 |
| Cochlear Americas | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,558 in reported general payments places this provider in the 65th percentile of 128 otolaryngology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 12 | $1,180 |
| Ipratropium Bromide | 14 | $392 |
| Omeprazole | 12 | $149 |
| Cephalexin | 29 | $117 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $73 |
| Tramadol Hcl | 16 | $15 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Medford
- Joseph ClarkeMedford$2K
- Mathew GeltzeilerPortland$221K
- Ryan LiPortland$160K
- Jeremiah AltPortland$89K
- Mark WaxPortland$20K
- Marcus MonroePortland$16K
- Joshua SchindlerPortland$8K
- Andrew BakerMilwaukie$8K
- Daniel ClayburghPortland$7K
- Timothy HullarPortland$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.